TrialResults-center.org
Search
Menu
Home
Search
Recent trials
Browse pathology
Browse treatment
About us
Avelumab
immune checkpoint inhibition
Description
Results
MSB0010718C - avelumab
Group by
Group by...
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
in first
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
in second
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
in third
All pathologies
Toggle Dropdown
All pathologies
lung cancer (metastatic)
renal-cell carcinoma (advanced)
urothelial carcinoma (advanced)
Question
all type of patients
582 - 233
all type of patients
711 - 233
all type of patients
675 - 233
first line
700 - 233
second line
701 - 233
Patients
death (overall survival)
progression or death (progression free survival PFS)
objective response (ORR)
Grade 3–5 drug-related AEs
complete response (CR)
pdf
pathology
Benefit (demonstrated or suggested) and harm
×
Modal title